| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.3 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.3 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.17 | 0.3 |